$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Sustained-release preparation capable of releasing a physiologically active substance 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/50
  • A61K-009/52
  • A61K-009/14
출원번호 US-0962347 (1997-10-31)
우선권정보 JP-0290441 (1996-10-31)
발명자 / 주소
  • Okada Hiroaki,JPX
  • Douken Yayoi,JPX
출원인 / 주소
  • Takeda Chemical Industries, Ltd., JPX
대리인 / 주소
    Wenderoth, Lind & Ponack, L.L.P.
인용정보 피인용 횟수 : 135  인용 특허 : 3

초록 ▼

Disclosed is a sustained-release preparation comprising 1) a polymer of lactic acid having a weight-average molecular weight of about 25,000 to about 60,000 and 2) a physiologically active substance, and which releases the physiologically active substance over a period of at least about 5 months; th

대표청구항 ▼

[ What we claim is:] [1.] A sustained-release preparation comprising 1) a hydrolyzed polymer of lactic acid having a weight-average molecular weight of about 25,000 to about 60,000 and a dispersity of about 1.2 to about 4.0 and 2) a physiologically active substance, which preparation releases the ph

이 특허에 인용된 특허 (3)

  1. Okada Hiroaki (Osaka JPX) Ogawa Yasuaki (Osaka JPX) Yashiki Takatsuka (Hyogo JPX), Method for producing microcapsule.
    상세보기
  2. Okada Hiroaki (Osaka JPX) Ogawa Yasuaki (Osaka JPX) Yashiki Takatsuka (Hyogo JPX), Method for producing microcapsule.
    상세보기
  3. Okada Hiroaki (Osaka JPX) Ogawa Yasuaki (Osaka JPX) Yashiki Takatsuka (Hyogo JPX), Prolonged release microcapsule.
    상세보기

이 특허를 인용한 특허 (135)

  1. Ly, Tai Wei, 3,5-diaminopyrazole kinase inhibitors.
    상세보기
  2. Ly, Tai Wei, 3,5-diaminopyrazole kinase inhibitors.
    상세보기
  3. Raaum, Erik Dean; Potter, Garrett Thomas; Ly, Tai Wei, 3,5-diaminopyrazole kinase inhibitors.
    상세보기
  4. Raaum, Erik Dean; Potter, Garrett Thomas; Ly, Tai Wei, 3,5-diaminopyrazole kinase inhibitors.
    상세보기
  5. Raaum, Erik Dean; Potter, Garrett Thomas; Ly, Tai Wei, 3,5-diaminopyrazole kinase inhibitors.
    상세보기
  6. Raaum, Erik Dean; Potter, Garrett Thomas; Ly, Tai Wei, 3,5-diaminopyrazole kinase inhibitors.
    상세보기
  7. Nistor, Catalin; Johnsson, Markus; Tiberg, Fredrik, Acid containing lipid formulations.
    상세보기
  8. Cociorva, Oana; Li, Bei; Szardenings, Anna Katrin; Fukuda, Yasumichi; Nomura, Masahiro; Seto, Shigeki; Yumoto, Kazuhiro; Okada, Kyoko; Nakamura, Ayako, Aminoquinolones as GSK-3 inhibitors.
    상세보기
  9. Cathers, Brian E.; Correa, Matthew Daniel; Hansen, Joshua; Lopez-Girona, Antonia; Khalil, Ehab M.; MacBeth, Kyle; Man, Hon-Wah; Muller, George W.; Pourdehnad, Michael; Raheja, Raj, Antiproliferative compounds and methods of use thereof.
    상세보기
  10. Cathers, Brian E.; Correa, Matthew Daniel; Hansen, Joshua; Lopez-Girona, Antonia; Khalil, Ehab M.; MacBeth, Kyle; Man, Hon-Wah; Muller, George W.; Pourdehnad, Michael; Raheja, Raj, Antiproliferative compounds and methods of use thereof.
    상세보기
  11. Hansen, Joshua; Correa, Matthew Daniel; Raheja, Raj; Lopez-Girona, Antonia; Man, Hon-Wah; Muller, George W.; Khalil, Ehab M.; MacBeth, Kyle; Cathers, Brian E.; Pourdehnad, Michael, Antiproliferative compounds and methods of use thereof.
    상세보기
  12. Alexander, Matthew D.; Correa, Matthew D.; Hansen, Joshua; Raheja, Raj Kumar; Sapienza, John, Antiproliferative compounds, and their pharmaceutical compositions and uses.
    상세보기
  13. Alexander, Matthew D.; Correa, Matthew D.; Hansen, Joshua; Raheja, Raj Kumar; Sapienza, John, Antiproliferative compounds, and their pharmaceutical compositions and uses.
    상세보기
  14. Liu, Gang, Azolyl urea compounds and methods of use thereof.
    상세보기
  15. Holladay, Mark W.; Liu, Gang; Rowbottom, Martin W., Biaryl acetamide compounds and methods of use thereof.
    상세보기
  16. Miyaji,Tatsuaki; Sato,Makoto; Murayama,Tamaki; Hoashi,Yohei; Saito,Hisae; Okada,Takao; Imamura,Yukari; Fujiyama,Yoshimichi, Bioabsorbable pharmaceutical formulation.
    상세보기
  17. Cleland, Jeffrey L.; Okumu, Franklin, Bioerodible polymers for injection.
    상세보기
  18. Yoshinaga,Kazuhiko; Akieda,Hideyuki, Biologically absorbable polyhydroxycarboxylic acid and production method thereof.
    상세보기
  19. Zhang, Jian; Armer, Thomas A., Cabergoline derivatives.
    상세보기
  20. Singh, Jaipal, Cerivastatin to treat pulmonary disorders.
    상세보기
  21. Hossainy, Syed F. A.; Tang, Yiwen; Michal, Eugene T.; Glauser, Thierry; Pacetti, Stephen D.; DesNoyer, Jessica, Coatings for implantable devices comprising polymers of lactic acid and methods for fabricating the same.
    상세보기
  22. Hossainy, Syed F.A.; Tang, Yiwen; Michal, Eugene T.; Glauser, Thierry; Pacetti, Stephen D.; DesNoyer, Jessica, Coatings for implantable devices comprising polymers of lactic acid and methods for fabricating the same.
    상세보기
  23. Wise, David, Compositions and methods for treating pelvic pain and other conditions.
    상세보기
  24. Sudhakar, Anantha, Compounds and methods for treatment of cancer.
    상세보기
  25. Surleraux, Dominique; Gosselin, Gilles, Compounds and pharmaceutical compositions for the treatment of viral infections.
    상세보기
  26. Yamamoto, Kazumichi; Yamada, Akiko; Hata, Yoshio, Controlled release composition and method of producing the same.
    상세보기
  27. Yamamoto, Kazumichi; Yamada, Akiko; Hata, Yoshio, Controlled release composition and method of producing the same.
    상세보기
  28. Yamamoto, Kazumichi; Yamada, Akiko; Hata, Yoshio, Controlled release composition and method of producing the same.
    상세보기
  29. Yamamoto,Kazumichi; Yamada,Akiko; Hata,Yoshio, Controlled release composition and method of producing the same.
    상세보기
  30. Johnsson, Markus; Tiberg, Fredrik; Nistor, Catalin, Controlled-release formulations.
    상세보기
  31. Li, Bei; Szardenings, Anna Katrin, Cyanoaminoquinolones and tetrazoloaminoquinolones as GSK-3 inhibitors.
    상세보기
  32. Gordon, Eric M., Deuterated O-sulfated beta lactam hydroxamic acids and deuterated N-sulfated beta lactams.
    상세보기
  33. Gordon, Eric M., Deuterated O-sulfated beta-lactam hydroxamic acids and deuterated N-sulfated beta-lactams.
    상세보기
  34. Lewis, Andrew L.; Stratford, Peter W.; Driver, Michael J., Drug delivery from stents.
    상세보기
  35. Lewis, Andrew L.; Stratford, Peter W.; Driver, Michael J., Drug delivery from stents.
    상세보기
  36. Lewis, Andrew L.; Stratford, Peter W.; Driver, Michael J., Drug delivery from stents.
    상세보기
  37. Shin, Hyeon-Cheol; Hwang, Hyejeong; Park, Kwang Yong; Kim, Seong Ho; Lee, Haengwoo, Eckol derivatives, methods of synthesis and uses thereof.
    상세보기
  38. Armer, Thomas; McKinley, Geoff; Borland, Scott; Guzman, Miguel; Szabolcs, Ármin; Gerencser, János, Ergoline compounds and uses thereof.
    상세보기
  39. Armer, Thomas; McKinley, Geoff; Borland, Scott; Guzman, Miguel; Szabolcs, Ármin; Gerencser, János, Ergoline compounds and uses thereof.
    상세보기
  40. Armer, Thomas; McKinley, Geoff; Borland, Scott; Guzman, Miguel; Szabolcs, Ármin; Gerencser, János, Ergoline compounds and uses thereof.
    상세보기
  41. Armer, Thomas; McKinley, Geoff; Borland, Scott; Guzman, Miguel; Szabolcs, Ármin; Gerencser, János, Ergoline compounds and uses thereof.
    상세보기
  42. Cleland, Jeffrey L.; Okumu, Franklin, Erodible polymers for injection.
    상세보기
  43. Cook, Robert O.; Zhang, Jian; Armer, Thomas A., Fluoroergoline analogs.
    상세보기
  44. Cook, Robert O.; Zhang, Jian; Armer, Thomas A., Fluoroergoline analogs.
    상세보기
  45. Cook, Robert O.; Zhang, Jian; Armer, Thomas A., Fluoroergoline analogs.
    상세보기
  46. Cook, Robert O.; Zhang, Jian; Armer, Thomas A., Fluoroergoline analogs.
    상세보기
  47. Cook, Robert O.; Zhang, Jian; Armer, Thomas A., Fluoroergoline analogs.
    상세보기
  48. Cook, Robert O.; Zhang, Jian; Armer, Thomas A., Fluoroergoline analogs.
    상세보기
  49. Joabsson, Fredrik; Johnsson, Markus; Tiberg, Fredrik, Glp-1 analogue formulations.
    상세보기
  50. Joabsson, Fredrik; Johnsson, Markus; Tiberg, Fredrik, GnRH analogue formulations.
    상세보기
  51. Hadd, Michael J.; Hocker, Michael D.; Holladay, Mark W.; Liu, Gang; Rowbottom, Martin W.; Xu, Shimin, Heterocyclic compounds and methods of use thereof.
    상세보기
  52. Hadd, Michael J.; Hocker, Michael D.; Holladay, Mark W.; Liu, Gang; Rowbottom, Martin W.; Xu, Shimin, Heterocyclic compounds and methods of use thereof.
    상세보기
  53. Hadd, Michael J.; Hocker, Michael D.; Holladay, Mark W.; Liu, Gang; Rowbottom, Martin W.; Xu, Shimin, Heterocyclic compounds and methods of use thereof.
    상세보기
  54. Albayrak,Celal, Induced phase transition method for the production of microparticles containing hydrophilic active agents.
    상세보기
  55. Albayrak, Celal, Induced phase transition method for the production of microparticles containing hydrophobic active agents.
    상세보기
  56. Castro, Alfredo C.; Peluso, Stephane; Snyder, Daniel A.; Tibbitts, Thomas T., Inhibitors of monoacylglycerol lipase and methods of their use.
    상세보기
  57. Zhang, Jian; Cook, Robert O., Iso-ergoline derivatives.
    상세보기
  58. Zhang, Jian; Cook, Robert O., Iso-ergoline derivatives.
    상세보기
  59. Zhang, Jian; Cook, Robert O., Iso-ergoline derivatives.
    상세보기
  60. Armer, Thomas; McKinley, Geoff; Borland, Scott; Guzman, Miguel, Isoergoline compounds and uses thereof.
    상세보기
  61. Armer, Thomas; McKinley, Geoff; Borland, Scott; Guzman, Miguel, Isoergoline compounds and uses thereof.
    상세보기
  62. Armer, Thomas; McKinley, Geoff; Borland, Scott; Guzman, Miguel, Isoergoline compounds and uses thereof.
    상세보기
  63. Ly, Tai Wei; Potter, Garrett Thomas, Isotopically enriched arylsulfonamide CCR3 antagonists.
    상세보기
  64. Ly, Tai Wei; Potter, Garrett Thomas, Isotopically enriched arylsulfonamide CCR3 antagonists.
    상세보기
  65. Abraham, Sunny; Chao, Qi; Hadd, Michael J.; Holladay, Mark W.; Liu, Gang; Setti, Eduardo, JAK kinase modulating compounds and methods of use thereof.
    상세보기
  66. Abraham, Sunny; Chao, Qi; Hadd, Michael J.; Holladay, Mark W.; Liu, Gang; Setti, Eduardo, JAK kinase modulating compounds and methods of use thereof.
    상세보기
  67. Abraham, Sunny; Chao, Qi; Hadd, Michael J.; Holladay, Mark W.; Liu, Gang; Setti, Eduardo, JAK kinase modulating compounds and methods of use thereof.
    상세보기
  68. Yamamoto, Kohei; Tani, Tsutomu; Aoki, Takashi; Hata, Yoshio, Lactic acid polymer and process for producing the same.
    상세보기
  69. Yamamoto,Kohei; Tani,Tsutomu; Aoki,Takashi; Hata,Yoshio, Lactic acid polymer and process for producing the same.
    상세보기
  70. Thuresson, Krister; Tiberg, Fredrik; Johansson, Markus; Harwigsson, Ian; Joabsson, Fredrik; Johnsson, Markus, Lipid depot formulations.
    상세보기
  71. Nistor, Catalin; Tiberg, Fredrik; Thuresson, Krister; Johnsson, Markus, Lipid formulations comprising a thiolated antioxidant.
    상세보기
  72. Thuresson, Krister; Tiberg, Fredrik; Johansson, Markus; Harwigsson, Ian; Joabsson, Fredrik; Johnsson, Markus, Liquid depot formulations.
    상세보기
  73. Estok, Thomas M.; Zaknoen, Sara L.; Mansfield, Robert K.; Lawhon, Tracy, Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders.
    상세보기
  74. Ron, Eyal S.; Langer, Robert S.; Crowley, Jr., William F., Methods and devices for the sustained release of multiple drugs.
    상세보기
  75. Ron, Eyal S.; Langer, Robert S.; Crowley, Jr., William F., Methods and devices for the sustained release of multiple drugs.
    상세보기
  76. Ron, Eyal S.; Langer, Robert S.; Crowley, Jr., William F., Methods and devices for the sustained release of multiple drugs.
    상세보기
  77. Ron, Eyal S.; Langer, Robert S.; Crowley, Jr., William F., Methods and devices for the sustained release of multiple drugs.
    상세보기
  78. Gualberto, Antonio; Scholz, Catherine Rose, Methods of treating cancer with farnesyltransferase inhibitors.
    상세보기
  79. Gualberto, Antonio; Scholz, Catherine Rose, Methods of treating cancer with farnesyltransferase inhibitors.
    상세보기
  80. Wu, Libo; Zhang, Jian, Methysergide derivatives.
    상세보기
  81. Oberegger, Werner; Eradiri, Okponanabofa; Zhou, Fang; Maes, Paul, Modified release tablet of bupropion hydrochloride.
    상세보기
  82. Cook, Robert O.; Zhang, Jian; Armer, Thomas A., Neuromodulatory compounds.
    상세보기
  83. Thuresson, Krister; Tiberg, Fredrik; Johansson, Markus; Harwigsson, Ian; Joabsson, Fredrik; Johnsson, Markus, Opioid depot formulations.
    상세보기
  84. Tiberg, Fredrik; Harwigsson, Ian; Johnsson, Markus, Opioid formulations.
    상세보기
  85. Johnsson, Markus; Joabsson, Fredrik; Nistor, Catalin; Thuresson, Krister; Tiberg, Fredrik, Peptide slow-release formulations.
    상세보기
  86. Johnsson, Markus; Tiberg, Fredrik, Pharmaceutical lipid compositions.
    상세보기
  87. Johnsson, Markus; Tiberg, Fredrik, Pharmaceutical lipid compositions.
    상세보기
  88. Ly, Tai Wei; Raaum, Erik Dean, Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors.
    상세보기
  89. Hostetler, Karl Y.; Beadle, James R.; Choo, Hyunah, Phosphono-pent-2-en-1-yl nucleosides and analogs.
    상세보기
  90. Zaveri, Nurulain; Meyer, Michael, Piperdinyl nociceptin receptor compounds.
    상세보기
  91. Yamamoto, Kazumichi; Saito, Kazuhiro; Hoshino, Tetsuo, Process for producing sustained-release composition.
    상세보기
  92. Rossling, Georg; Albayrak, Celal; Tack, Johannes; Schmitz, Reinhard, Process for the production of morphologically uniform microcapsules and microcapsules that are produced according to this process.
    상세보기
  93. Ren, Pingda; Martin, Michael; Isbester, Paul; Lane, Benjamin S.; Kropp, Jason, Processes for preparing isoquinolinones and solid forms of isoquinolinones.
    상세보기
  94. Ren, Pingda; Martin, Michael; Isbester, Paul; Lane, Benjamin S.; Kropp, Jason, Processes for preparing isoquinolinones and solid forms of isoquinolinones.
    상세보기
  95. Ren, Pingda; Martin, Michael; Isbester, Paul; Lane, Benjamin S.; Kropp, Jason, Processes for preparing isoquinolinones and solid forms of isoquinolinones.
    상세보기
  96. Hadd, Michael J.; Holladay, Mark W.; Rowbottom, Martin, Quinazoline compounds and methods of use thereof.
    상세보기
  97. Abraham, Sunny; Bhagwat, Shripad S.; Campbell, Brian T.; Chao, Qi; Faraoni, Raffaella; Holladay, Mark W.; Lai, Andiliy G.; Rowbottom, Martin W.; Setti, Eduardo; Sprankle, Kelly G., RAF kinase modulator compounds and methods of use thereof.
    상세보기
  98. Abraham, Sunny; Bhagwat, Shripad S.; Campbell, Brian T.; Chao, Qi; Faraoni, Raffaella; Holladay, Mark W.; Lai, Andiliy G.; Rowbottom, Martin W.; Setti, Eduardo; Sprankle, Kelly G., RAF kinase modulator compounds and methods of use thereof.
    상세보기
  99. Abraham, Sunny; Bhagwat, Shripad S.; Campbell, Brian T.; Chao, Qi; Faraoni, Raffaella; Holladay, Mark W.; Lai, Andiliy G.; Rowbottom, Martin W.; Setti, Eduardo; Sprankle, Kelly G., RAF kinase modulator compounds and methods of use thereof.
    상세보기
  100. Abraham, Sunny; Bhagwat, Shripad S.; Campbell, Brian T.; Chao, Qi; Faraoni, Raffaella; Holladay, Mark W.; Lai, Andiliy G.; Rowbottom, Martin W.; Setti, Eduardo; Sprankle, Kelly G., RAF kinase modulator compounds and methods of use thereof.
    상세보기
  101. Abraham, Sunny; Bhagwat, Shripad S.; Campbell, Brian T.; Chao, Qi; Faraoni, Raffaella; Holladay, Mark W.; Lai, Andiliy G.; Rowbottom, Martin W.; Setti, Eduardo; Sprankle, Kelly G., RAF kinase modulator compounds and methods of use thereof.
    상세보기
  102. Hara, Takahito; Kusaka, Masami, Remedies for sex hormone dependent disease.
    상세보기
  103. Tiberg, Fredrik; Johnsson, Markus, Robust controlled-release formulations.
    상세보기
  104. Tiberg, Fredrik; Johnsson, Markus, Robust controlled-release peptide formulations.
    상세보기
  105. Wang, Binghe; Tai, Phang-Cheng; Jin, Jinshan; Hsieh, Yinghsin; Ritter, Ying-Ju; Cui, Jianmei; Chaudhary, Arpana S.; Dai, Chaofeng; Damera, Krishna; Chen, Weixuan, SecA inhibitors and methods of making and using thereof.
    상세보기
  106. Shreder, Kevin; Hu, Yi; Fraser, Allister; Kohno, Yasushi; Kojima, Akihiko; Ishiyama, Junichi, Serine hydrolase inhibitors.
    상세보기
  107. Gross, Timothy David, Solid forms comprising optically active pyrazolylaminoquinazoline, compositions thereof, and uses therewith.
    상세보기
  108. Ren, Pingda; Martin, Michael; Isbester, Paul; Lane, Benjamin S.; Kropp, Jason, Solid forms of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1 (2H)-one and methods of use thereof.
    상세보기
  109. Fernandez, Paul F.; Ferretti, Antonio C.; Kothare, Mohit A.; Li, Ying; Man, Hon-Wah; Zhang, Weihong, Solid forms of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and uses.
    상세보기
  110. Mansfield, Robert K.; Lawhon, Tracy; Dymock, Brian, Solid state forms of macrocyclic kinase inhibitors.
    상세보기
  111. Joabsson, Fredrik; Johnsson, Markus; Norlin, Andreas; Tiberg, Fredrik, Somatostatin analogue formulations.
    상세보기
  112. Cociorva, Oana; Fukuda, Yasumichi; Kohno, Yasushi; Li, Bei; Okada, Kyoko; Nakamura, Ayako; Nomura, Masahiro; Seto, Shigeki; Szardenings, Anna Katrin; Yumoto, Kazuhiro, Spirocyclic aminoquinolones as GSK-3 inhibitors.
    상세보기
  113. Cociorva, Oana; Fukuda, Yasumichi; Kohno, Yasushi; Li, Bei; Okada, Kyoko; Nakamura, Ayako; Nomura, Masahiro; Seto, Shigeki; Szardenings, Anna Katrin; Yumoto, Kazuhiro, Spirocyclic aminoquinolones as GSK-3 inhibitors.
    상세보기
  114. Zhang, Jian; Cook, Robert O.; Armer, Thomas A.; Kosarev, Sergey Alexandrovich; Xie, Dejian, Substituted indolo 4,3 FG quinolines useful for treating migraine.
    상세보기
  115. Margaron, Philippe Maria Clotaire; Dadey, Eric; Lindemann, Christopher M.; Li, Ruihong, Sustained delivery formulations of rapamycin compounds.
    상세보기
  116. Okumu, Franklin; Cleland, Jeffrey L., Sustained release formulation.
    상세보기
  117. Okumu,Franklin, Sustained release formulations.
    상세보기
  118. Futo, Tomomichi; Saito, Kazuhiro; Hoshino, Tetsuo; Hori, Masuhisa, Sustained-release composition and method for producing the same.
    상세보기
  119. Futo, Tomomichi; Saito, Kazuhiro; Hoshino, Tetsuo; Hori, Masuhisa, Sustained-release composition and method for producing the same.
    상세보기
  120. Futo, Tomomichi; Saito, Kazuhiro; Hoshino, Tetsuo; Hori, Masuhisa, Sustained-release composition and method for producing the same.
    상세보기
  121. Saito, Kazuhiro; Futo, Tomomichi; Hoshino, Tetsuo, Sustained-release preparations.
    상세보기
  122. Joabsson, Fredrik; Linden, Margareta; Thuresson, Krister; Tiberg, Fredrik, Topical bioadhesive formulations.
    상세보기
  123. Joabsson, Fredrik; Linden, Margareta; Thuresson, Krister; Tiberg, Fredrik, Topical bioadhesive formulations.
    상세보기
  124. Joabsson, Fredrik; Linden, Margareta; Thuresson, Krister; Tiberg, Fredrik, Topical bioadhesive formulations.
    상세보기
  125. Moore, Keith A.; Heasley, Ralph A.; Greiwe, Jeffrey S.; Facemire, John W.; Modest, Jason D., Tranexamic acid formulations.
    상세보기
  126. Moore, Keith A.; Heasley, Ralph A.; Greiwe, Jeffrey S.; Facemire, John W.; Modest, Jason D., Tranexamic acid formulations.
    상세보기
  127. Moore, Keith A.; Heasley, Ralph A.; Greiwe, Jeffrey S.; Facemire, John W.; Modest, Jason D., Tranexamic acid formulations.
    상세보기
  128. Moore, Keith A.; Heasley, Ralph A.; Greiwe, Jeffrey S.; Facemire, John W.; Modest, Jason D., Tranexamic acid formulations.
    상세보기
  129. Moore, Keith A.; Heasley, Ralph A.; Greiwe, Jeffrey S.; Facemire, John W.; Modest, Jason D., Tranexamic acid formulations.
    상세보기
  130. Moore, Keith A.; Heasley, Ralph A.; Greiwe, Jeffrey S.; Facemire, John W.; Modest, Jason D., Tranexamic acid formulations.
    상세보기
  131. Moore, Keith A.; Heasley, Ralph A.; Greiwe, Jeffrey S.; Facemire, John W.; Modest, Jason D., Tranexamic acid formulations.
    상세보기
  132. Heasley, Ralph A.; Moore, Keith A.; Greiwe, Jeffrey S.; Facemire, John W.; Modest, Jason D., Tranexamic acid formulations with reduced adverse effects.
    상세보기
  133. McGee, Kevin; Zook, Scott; Carr, Andrew; Bonnaud, Thierry, Valbenazine salts and polymorphs thereof.
    상세보기
  134. Pacetti, Stephen Dirk; Roorda, Wouter Erik, Zwitterionic terpolymers, method of making and use on medical devices.
    상세보기
  135. Pacetti, Stephen; Roorda, Wouter Erik, Zwitterionic terpolymers, method of making and use on medical devices.
    상세보기

관련 콘텐츠

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로